Clinical trial
A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
NCT01184456 is registered in ClinicalTrials.gov with AIDS Healthcare Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System
- Lead sponsor
- AIDS Healthcare Foundation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- July 31, 2012
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal symptoms, hiv infection